Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BNGO | Stock Option (Right to Buy) | Award | $0 | +44.5K | $0.00 | 44.5K | Jun 30, 2020 | Common Stock | 44.5K | $0.51 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan). |
F2 | The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029. |